National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide (Symtuza®) is indicated for the treatment of HIV-1 in adults and adolescents.

NCPE Rapid Review Process Complete
Rapid review received 27/09/2017
Rapid review completed 26/10/2017
Rapid Review outcome Full pharmacoeconomic assessment not recommended